{"id":"NCT02670915","sponsor":"Novo Nordisk A/S","briefTitle":"Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes","officialTitle":"Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-05-04","primaryCompletion":"2018-02-05","completion":"2018-03-03","firstPosted":"2016-02-02","resultsPosted":"2019-04-04","lastUpdate":"2019-06-05"},"enrollment":834,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 1"],"interventions":[{"type":"DRUG","name":"Faster-acting insulin aspart","otherNames":[]},{"type":"DRUG","name":"insulin aspart","otherNames":[]},{"type":"DRUG","name":"insulin degludec","otherNames":[]}],"arms":[{"label":"Meal-time faster-acting insulin aspart and insulin degludec","type":"EXPERIMENTAL"},{"label":"Meal-time NovoRapid® (insulin aspart) and insulin degludec","type":"ACTIVE_COMPARATOR"},{"label":"Post-meal faster-acting insulin aspart and insulin degludec","type":"EXPERIMENTAL"}],"summary":"This trial is conducted globally. The aim of the trial is to investigate efficacy and safety of faster-acting insulin aspart compared to NovoRapid® both in combination with insulin degludec in children and adolescents with type 1 diabetes.","primaryOutcome":{"measure":"Change in the Percentage of HbA1c","timeFrame":"Week 0, Week 26","effectByArm":[{"arm":"Faster Aspart (Meal)","deltaMin":7.57,"sd":0.8},{"arm":"Faster Aspart (Post)","deltaMin":7.58,"sd":0.84},{"arm":"NovoRapid (Meal)","deltaMin":7.53,"sd":0.83}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG002","p":"=0.007"}]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":155,"countries":["United States","Bulgaria","Czechia","Estonia","Finland","Germany","India","Israel","Italy","Japan","Latvia","Lithuania","Poland","Puerto Rico","Russia","Serbia","Turkey (Türkiye)","Ukraine"]},"refs":{"pmids":["31076415"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":261},"commonTop":["Viral upper respiratory tract infection","Upper respiratory tract infection","Headache","Pyrexia","Gastroenteritis"]}}